Publication Date:
2012-10-15
Description:
Cardiovascular diseases are the world’s number one cause of death, accounting for 17.1 million deaths a year. New high-resolution molecular and structural imaging strategies are needed to understand underlying pathophysiological mechanism. The aim of our study is (1) to provide a molecular basis of the heart animal model through the local identification of biomolecules by mass spectrometry imaging (MSI) (three-dimensional (3D) molecular reconstruction), (2) to perform a cross-species validation of secondary ion mass spectrometry (SIMS)-based cardiovascular molecular imaging, and (3) to demonstrate potential clinical relevance by the application of this innovative methodology to human heart specimens. We investigated a MSI approach using SIMS on the major areas of a rat and mouse heart: the pericardium, the myocardium, the endocardium, valves, and the great vessels. While several structures of the heart can be observed in individual two-dimensional sections analyzed by metal-assisted SIMS imaging, a full view of these structures in the total heart volume can be achieved only through the construction of the 3D heart model. The images of 3D reconstruction of the rat heart show a highly complementary localization between Na + , K + , and two ions at m/z 145 and 667. Principal component analysis of the MSI data clearly identified different morphology of the heart by their distinct correlated molecular signatures. The results reported here represent the first 3D molecular reconstruction of rat heart by SIMS imaging. Figure Workflow of the 3D reconstruction. A Tissue section, B gold deposition is done by sputter coating, C , C1 SIMS-ToF mass analyzer, C , C2 mass spectral peaks, C , C3 datacube images; D , E Reconstruction of the heart showing 3D-spatial distributions of three different ions 145 m/z ( red ), 23 m/z ( green ), and 39 m/z ( blue ); F coregistration of 40 individual MS imaging Content Type Journal Article Category Original Paper Pages 1-12 DOI 10.1007/s00216-012-6451-3 Authors Lara Fornai, Cardiovascular Pathology, Department of Cardiac, Thoracic and Vascular Sciences, University of Padua, Via Gabelli 61, 35121 Padua, Italy Annalisa Angelini, Cardiovascular Pathology, Department of Cardiac, Thoracic and Vascular Sciences, University of Padua, Via Gabelli 61, 35121 Padua, Italy Ivo Klinkert, FOM-AMOLF, Science Park 104, 1098 XG, Amsterdam, The Netherlands Frans Giskes, FOM-AMOLF, Science Park 104, 1098 XG, Amsterdam, The Netherlands Andras Kiss, FOM-AMOLF, Science Park 104, 1098 XG, Amsterdam, The Netherlands Gert Eijkel, FOM-AMOLF, Science Park 104, 1098 XG, Amsterdam, The Netherlands Erika A. Amstalden-van Hove, FOM-AMOLF, Science Park 104, 1098 XG, Amsterdam, The Netherlands Leendert A. Klerk, FOM-AMOLF, Science Park 104, 1098 XG, Amsterdam, The Netherlands Marny Fedrigo, Cardiovascular Pathology, Department of Cardiac, Thoracic and Vascular Sciences, University of Padua, Via Gabelli 61, 35121 Padua, Italy Giuseppe Pieraccini, CISM Mass Spectrometry Centre, Viale Pieraccini 6 University of Florence, 50139 Florence, Italy Gloriano Moneti, CISM Mass Spectrometry Centre, Viale Pieraccini 6 University of Florence, 50139 Florence, Italy Marialuisa Valente, Cardiovascular Pathology, Department of Cardiac, Thoracic and Vascular Sciences, University of Padua, Via Gabelli 61, 35121 Padua, Italy Gaetano Thiene, Cardiovascular Pathology, Department of Cardiac, Thoracic and Vascular Sciences, University of Padua, Via Gabelli 61, 35121 Padua, Italy Ron M. A. Heeren, FOM-AMOLF, Science Park 104, 1098 XG, Amsterdam, The Netherlands Journal Analytical and Bioanalytical Chemistry Online ISSN 1618-2650 Print ISSN 1618-2642
Print ISSN:
1618-2642
Topics:
Chemistry and Pharmacology
Permalink